Jones Soda Co. Announces Completed Acquisition of UCAN Functional Nutrition Brand Assets Through Jones Labs
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Jones Soda (JSDA) completed its acquisition of substantially all UCAN functional nutrition operating assets through Jones Labs on November 12, 2026. Terms included approximately $700,000 in cash and approximately $500,000 in assumed liabilities. Those liabilities include approximately $400,000 of licensing fees payable in January 2027, with approximately $200,000 to be satisfied in common shares issued to Glycologic Limited at the market price at issuance.
Seller-provided figures show UCAN operations generated approximately $4.9 million in net revenue and $1.9 million in gross profit in the nine months ended September 30, 2026; full-year revenue was projected at approximately $6 million. These are pre-acquisition figures, not Jones Soda results or assurances of future performance. Jones Soda expects UCAN growth in 2027 and expansion of its direct-to-consumer business, subject to successful integration.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate pointCompleted UCAN asset acquisition adds the functional nutrition business through Jones Labs, advancing Jones Soda's stated strategy.
- Minor point. Forward-looking: it has not happened yet and may not happen.Integration plans target operational efficiencies by combining UCAN products, customer relationships and distribution with existing systems and personnel.
- Minor point. Forward-looking: it has not happened yet and may not happen.2027 UCAN growth is expected by Jones Soda, leveraging its commercial infrastructure and customer relationships.
- Minor point. Forward-looking: it has not happened yet and may not happen.Direct-to-consumer expansion is expected from UCAN's activities, subject to successful integration.
Negative
- Moderate pointApproximately $700,000 cash consideration was paid for the UCAN operating assets. 2.3% of market cap
- Minor pointApproximately $500,000 assumed liabilities include approximately $400,000 licensing fees payable January 2027 and approximately $100,000 other liabilities.
- Minor point. Forward-looking: it has not happened yet and may not happen.Approximately $200,000 in common shares will satisfy licensing obligations to Glycologic Limited, diluting holders at market price upon issuance.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Acquisition advances functional health and nutrition strategy; integration targets operational synergies and 2027 growth through Jones Club and retail channels
The acquisition advances the Company's functional health and nutrition strategy discussed in connection with its third-quarter 2026 financial results. Jones Soda intends to integrate UCAN's products, brand, customer relationships and distribution channels into its existing systems, processes and personnel to maximize operational efficiencies and synergies.
Based on historical financial information provided by the seller, UCAN-related operations generated approximately
UCAN Functional Nutrition Portfolio
UCAN is a metabolic performance nutrition brand focused on sustained energy, endurance and active lifestyles. Its portfolio includes energy gels, nutrition bars, drink mixes, hydration products and protein nutrition offerings marketed to athletes and active consumers. Certain products incorporate LIVSTEADY™ carbohydrate technology.
Strategic Rationale
Scott Harvey, Chief Executive Officer of Jones Soda, commented:
"The UCAN acquisition represents a tangible step forward in our functional health and nutrition strategy. We believe UCAN has significantly untapped growth potential by reaching consumers through new channels focused on metabolic health, performance nutrition and everyday wellness. Our priority is to identify and develop distribution opportunities that align with these consumer needs while leveraging Jones Soda's infrastructure, operational capabilities and resources to support scalable growth and meaningful operating efficiencies."
"We expect to grow the UCAN business in 2027, leveraging our commercial infrastructure and customer relationships. We also expect UCAN's direct-to-consumer activities to expand the scale of our existing DTC business, subject to successful integration."
Transaction Overview
The transaction closed November 12, 2026. In addition to approximately
About Jones Soda Co.
Jones Soda Co.® (CSE: JSDA, OTCQB: JSDA) markets and distributes premium craft sodas under the Jones® Soda brand across North America. The Company is headquartered in Seattle, Washington. For more information, visit www.jonessoda.com.
Forward-Looking Statements
Statements about expected 2027 UCAN growth, distribution expansion, Jones Club opportunities, integration, operating synergies and future results are forward-looking statements under applicable U.S. and Canadian securities laws. Actual results may differ materially due to risks including customer retention, product demand, licensing and intellectual-property rights, regulatory compliance, integration costs, retail performance, working-capital requirements and financing needs, as well as risks described in the Company's SEC filings, including its 2025 Form 10-K and September 30, 2026 Form 10-Q. Forward-looking statements speak only as of their date, and the Company undertakes no obligation to update them except as required by law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/jones-soda-co-announces-completed-acquisition-of-ucan-functional-nutrition-brand-assets-through-jones-labs-302939876.html
SOURCE Jones Soda Co.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When did Jones Soda complete the UCAN acquisition, and what were the terms?
Jones Soda completed the acquisition through Jones Labs on November 12, 2026, for approximately $700,000 in cash and approximately $500,000 in assumed liabilities. The transaction covered substantially all operating assets associated with the UCAN functional nutrition brand.
What growth does Jones Soda expect from the UCAN acquisition?
Jones Soda expects to grow UCAN in 2027 using its commercial infrastructure and customer relationships. It also expects UCAN's direct-to-consumer activities to expand its existing direct-to-consumer business, subject to successful integration.